Mads Assenholt Nielsen, Jakob Bjerager, Gülsenay Citirak, Lars Morten Holm, Esben Nielsen, Yousif Subhi, Amardeep Singh
{"title":"Patient-reported visual function outcomes in immediately sequential versus delayed sequential bilateral cataract surgery.","authors":"Mads Assenholt Nielsen, Jakob Bjerager, Gülsenay Citirak, Lars Morten Holm, Esben Nielsen, Yousif Subhi, Amardeep Singh","doi":"10.1111/aos.16785","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To compare patient-reported visual function outcomes of immediate sequential bilateral cataract surgery (ISBCS) and delayed sequential bilateral cataract surgery (DSBCS).</p><p><strong>Methods: </strong>Single-center, randomised controlled trial of patients eligible for bilateral cataract surgery allocated to ISBCS or DSBCS. Patients filled out the Catquest-7SF questionnaire before surgery, 1 week after surgery, and 3 months after surgery.</p><p><strong>Results: </strong>Ninety-eight patients were included for analysis (ISBCS = 51; DSBCS = 47). In both groups, there was a statistically significant improvement in Catquest-7SF patient-reported outcomes after surgery (p < 0.001), and no difference between the ISBCS and DSBCS groups (p ≥ 0.424). At both 1 week and 3 months post-surgery, a statistically significantly higher proportion of patients were \"very satisfied\" with the surgical approach in the ISBCS group (94.1% at both 1 week and 3 months) compared to the DSBCS group (55.3% at 1 week and 63.8% at 3 months), both p < 0.001.</p><p><strong>Conclusions: </strong>Both ISBCS and DSBCS are effective options to treat bilateral cataracts with no statistically significant difference in patient-reported vision outcomes. However, we found postoperative satisfaction with the surgical approach to be higher among ISBCS patients, which suggests that ISBCS-related benefits, such as fewer health care visits and shorter vision rehabilitation, are compelling to patients.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/aos.16785","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To compare patient-reported visual function outcomes of immediate sequential bilateral cataract surgery (ISBCS) and delayed sequential bilateral cataract surgery (DSBCS).
Methods: Single-center, randomised controlled trial of patients eligible for bilateral cataract surgery allocated to ISBCS or DSBCS. Patients filled out the Catquest-7SF questionnaire before surgery, 1 week after surgery, and 3 months after surgery.
Results: Ninety-eight patients were included for analysis (ISBCS = 51; DSBCS = 47). In both groups, there was a statistically significant improvement in Catquest-7SF patient-reported outcomes after surgery (p < 0.001), and no difference between the ISBCS and DSBCS groups (p ≥ 0.424). At both 1 week and 3 months post-surgery, a statistically significantly higher proportion of patients were "very satisfied" with the surgical approach in the ISBCS group (94.1% at both 1 week and 3 months) compared to the DSBCS group (55.3% at 1 week and 63.8% at 3 months), both p < 0.001.
Conclusions: Both ISBCS and DSBCS are effective options to treat bilateral cataracts with no statistically significant difference in patient-reported vision outcomes. However, we found postoperative satisfaction with the surgical approach to be higher among ISBCS patients, which suggests that ISBCS-related benefits, such as fewer health care visits and shorter vision rehabilitation, are compelling to patients.
期刊介绍:
Acta Ophthalmologica is published on behalf of the Acta Ophthalmologica Scandinavica Foundation and is the official scientific publication of the following societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER).
Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.